Wian de Jongh | CEO
adaptvac

Pre-Congress Workshops - Monday 30th March @ 10:00

VACCINE TECHNOLOGY WORKSHOP

Topics:

• Cutting-edge technologies shaping the future of vaccine development.  
• Adjuvants
• AI tools for Protein Design/Epitopes

Workshop Chair: Dr David Burkhart, Chief Executive Officer, Inimmune

10:00 Chair’s Opening Remarks

10.10 Self-replicating RNA Platform Development

10.25 Designing the Next Generation of Vaccines: Harnessing Generative AI for In Silico Immunogen Discovery

10.40 A Versatile Platform Technology Enabling Development Of cVLP Vaccines Within Infectious and Non-Communicable Diseases

10:55 Engineering Modular Immunogen Platforms to Neutralize Evolving Chemical Threats 

11:10 A Modified Sarna Platform Technology for the Development of A Pan-Filovirus Vaccine

11:25 Killed Whole Cell Genome Reduced Bacterial Vaccines: A New Rapid, Inexpensive, Easily Manufactured, Thermostable Platform

11:40- Q&A

12:00 Panel: The Evolving Landscape of Novel Adjuvant Development – Navigating Safety, Access and Innovation

• Safety as a priority and hurdle for the acceptance novel adjuvants
• How can we further de-risk adjuvants?
• Changing Models in licensing and access, how will non-exclusive licensing change the field?
• Can innovation and adoption of new technologies overcome barriers in cost and access? 

David Burkhart, CEO, Inimmune Corp

Andrew Geall, Chief Development Officer, Replicate Bioscience, Inc.

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Session led by:

×

Wian de Jongh / VACCINE TECHNOLOGY WORKSHOP

Wian de Jongh, CEO,
adaptvac

Dr. de Jongh has a M.Sc. in Chemical Engineering from the University of Stellenbosch, South Africa and was awarded a doctorate in Biotechnology from the Technical University of Denmark (DTU). Furthermore, he was awarded an affiliated associate professorship at DTU in 2017. Dr. de Jongh has 20 years ...

CloseMore

Reda Rawi, Head Structural Bioinformatics Core, Vaccine Research Center, NIAID, NIH

Roland Ventura, Head of Strategy, Vaccine Formulation Institute

×

Roland Ventura / VACCINE TECHNOLOGY WORKSHOP

Roland Ventura, Head of Strategy,
Vaccine Formulation Institute

Roland Ventura holds a PhD in molecular biology and vaccines from the Queen’s University Belfast.  After postdoctoral training at the University of Oxford he worked with Dako A/S in Denmark under a European Commission-funded Marie Curie Transfer of Knowledge Fellowship.  Following this, he became...

CloseMore

Adolfo Garcia-Sastre, Professor In The Department of Microbiology, Icahn School of Medicine at Mount Sinai

Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Health - NIAID

×

Wolfgang Leitner / VACCINE TECHNOLOGY WORKSHOP

Wolfgang Leitner, Chief, Innate Immunity Section,
National Institute of Health - NIAID

Wolfgang Leitner is the chief of the Innate Immunity Section of the Basic Immunology Branch (BIB) / Division of Allergy, Immunology and Transplantation (DAIT), at the National Institute of Allergy and Infectious Diseases (NIAID/NIH). He oversees the NIAID Vaccine Adjuvant Program, and his section...

CloseMore

Ken J. Ishii, Director and Professor, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo

×

Ken J. Ishii / VACCINE TECHNOLOGY WORKSHOP

Ken J. Ishii, Director and Professor,
International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo

Prof. Ken J. Ishii, M.D., Ph.D., currently Director for Int. Vaccine Design Center, The Institute of Medical Science, the University of Tokyo, has 27 years of experience in Vaccine R&D since 1998 including 7 years as a IND reviewer at US Food and Drug Administration (FDA), 15 years as a basic...

CloseMore

Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Health - NIAID

×

Wolfgang Leitner / VACCINE TECHNOLOGY WORKSHOP

Wolfgang Leitner, Chief, Innate Immunity Section,
National Institute of Health - NIAID

Wolfgang Leitner is the chief of the Innate Immunity Section of the Basic Immunology Branch (BIB) / Division of Allergy, Immunology and Transplantation (DAIT), at the National Institute of Allergy and Infectious Diseases (NIAID/NIH). He oversees the NIAID Vaccine Adjuvant Program, and his section...

CloseMore

Stephanie Monticelli, Principal Investigator, United States Army Medical Research Institute of Infectious Disease (USAMRIID)

Steven Zeichneer, Professor, University of Virginia